Stock listing
NASDAQ:CTIC CTi Biopharma Corp Stock
Follow CTi Biopharma Corp into a list and get an email when it puts out news.
Last close · NASDAQ:CTIC
$9.09 USD
Close on Jun 26, 2023 · No longer trades
- Lowest – highest close
- $0.64 – $9.10 USDSince Jan 3, 2017 · lowest Aug 9, 2019 · highest Jun 21, 2023
Delisted NASDAQ:CTIC no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.
- Ticker
- NASDAQ:CTIC
- Asset type
- Stock
- Exchange
- NASDAQ
- Currency
- USD
CTi Biopharma Corp on 6ix
- Calls
- 5 calls with a replay · 5 with a transcript · latest Mar 6, 2023
- Decks
- 16 decks · latest Sep 28, 2022
Events
| Call | When | Status |
|---|---|---|
| CTI Biopharma (CTIC) Q4 2022 Earnings Call | Mon, Mar 06, 2023 · 4:30 PM ET | Replay |
| CTI Biopharma (CTIC) Q3 2022 Earnings Call | Mon, Nov 07, 2022 · 4:30 PM ET | Replay |
| CTI Biopharma (CTIC) Q2 2022 Earnings Call | Mon, Aug 08, 2022 · 4:30 PM ET | Replay |
| CTI Biopharma (CTIC) Q1 2022 Earnings Call | Thu, May 12, 2022 · 4:30 PM ET | Replay |
| CTI Biopharma (CTIC) Q2 2021 Earnings Call | Thu, Aug 05, 2021 | Replay |
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Investor Presentation (September 2022) | Investor deck | 24 slides | Sep 28, 2022 |
| Investor Presentation (January 2018) | Investor deck | 27 slides | Jan 5, 2018 |
| Investor Presentation (November 2017) | Investor deck | 32 slides | Nov 13, 2017 |
| Investor Presentation (January 2017) | Investor deck | 36 slides | Jan 9, 2017 |
| Investor Presentation (January 2015) | Investor deck | 33 slides | Jan 13, 2015 |
| Investor Presentation (September 2014) | Investor deck | 27 slides | Sep 16, 2014 |
| Cell Therapeutics — Investor Presentation (September 2012) | Investor deck | 37 slides | Sep 10, 2012 |
| Cell Therapeutics — Investor Presentation (November 2011) | Investor deck | 23 slides | Nov 7, 2011 |
| Cell Therapeutics — Merger or Acquisition (March 2011) | Merger or acquisition | 32 slides | Mar 14, 2011 |
| Cell Therapeutics — Merger or Acquisition (March 2011) | Merger or acquisition | 7 slides | Mar 14, 2011 |
All 16 decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Cell Therapeutics — Investor Presentation (November 2010) | Investor deck | 8 slides | Nov 17, 2010 |
| Cell Therapeutics — JP Morgan Healthcare Conference 2010 | Conference | 22 slides | Jan 11, 2010 |
| Cell Therapeutics — Investor Presentation (November 2009) | Investor deck | 19 slides | Nov 16, 2009 |
| Cell Therapeutics — Merger or Acquisition (June 2003) | Merger or acquisition | 62 slides | Jun 26, 2003 |
| Cell Therapeutics — Shareholder Meeting (June 2003) | Shareholder meeting | 67 slides | Jun 25, 2003 |
| Cell Therapeutics — Merger or Acquisition (June 2003) | Merger or acquisition | 4 slides | Jun 20, 2003 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Mark N Lampert Other companies: Immunic, Inc. (Director · Since at least Feb 17, 2026); Kymera Therapeutics, Inc. (Director · Since at least Jan 11, 2023); Olema Pharmaceuticals, Inc. (Director · Since at least Jun 10, 2022); MoonLake Immunotherapeutics (Director · Since at least Apr 5, 2022); Rain Oncology Inc (Director · Nov 8, 2022 – Jan 25, 2024 · Past) | Director · Aug 9, 2022 – Jun 26, 2023 · Past |
| Adam Craig Other companies: X4 Pharmaceuticals, Inc. (Executive Chair · Since at least Aug 12, 2025); Sunesis Pharmaceuticals Inc (EVP, Development & CMO · Feb 27, 2012 – Feb 27, 2015 · Past) | President and CEO, Director · Mar 20, 2017 – Jun 26, 2023 · Past |
| David Kirske Other companies: X4 Pharmaceuticals, Inc. (Chief Financial Officer · Since at least Aug 12, 2025) | EVP, Chief Financial Officer · Jul 1, 2020 – Jun 26, 2023 · Past |
| Frederick W. Telling Other companies: Oragenics Inc. (Executive Chairman · Since at least Nov 14, 2011) | Director · Nov 11, 2011 – Sep 18, 2018 · Past |
| Phillip M Phd Nudelman | Director · Sep 23, 2015 – Apr 29, 2017 · Past |
Log in to ask 6ix AI your own questions about CTi Biopharma Corp.